Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT ID: NCT00043758
Last Updated: 2005-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
170 participants
INTERVENTIONAL
2002-07-31
2004-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tolvaptan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Desert Cardiology of Tucson
Tucson, Arizona, United States
Arkansas Heart
Little Rock, Arkansas, United States
San Diego Cardiac Center
San Diego, California, United States
Northern California Medical Associates
Santa Rosa, California, United States
Cardiovascular Consultants Medical Group, Inc.
Walnut Creek, California, United States
University of Colorado
Denver, Colorado, United States
The Hoffman Heart Institute of CT/St. Francis Hospital
Hartford, Connecticut, United States
Yale University
New Haven, Connecticut, United States
Cardiology Associates of Fort Lauderdale
Fort Lauderdale, Florida, United States
Cardiovascular Research Center of South Florida
Miami, Florida, United States
Charlotte Heart Group
Port Charlotte, Florida, United States
The Heart and Vascular Institute of Florida
St. Petersburg, Florida, United States
Cardiovascular Associates of Augusta, PA
Augusta, Georgia, United States
Georgia Heart Specialists
Covington, Georgia, United States
Illinois Heart and Lung Associates, SC
Normal, Illinois, United States
The Care Group, LLC
Indianapolis, Indiana, United States
Medical Research Institute
Slidell, Louisiana, United States
Androscoggin Cardiology Associates
Auburn, Maine, United States
Maine Cardiology Associates
Portland, Maine, United States
Pentucket Medical Associates
Haverhill, Massachusetts, United States
Mystic Cardiology Associates, Inc.
Medford, Massachusetts, United States
Harper Hospital/Wayne State University
Detroit, Michigan, United States
John Dingell VA Medical Center
Detroit, Michigan, United States
St. Luke's-Roosevelt Hospital Center
New York, New York, United States
South Bay Cardiovascular Associates
West Islip, New York, United States
The Lindner Clinical Trial Center
Cincinnati, Ohio, United States
Midwest Cardiology Research Foundation
Columbus, Ohio, United States
North Ohio Research LTD
Lorraine, Ohio, United States
North Ohio Research LTD.
Sandusky, Ohio, United States
Medical College of Pennsylvania
Philadelphia, Pennsylvania, United States
Guthrie Clinic, LTD
Sayre, Pennsylvania, United States
Miriam Hospital
Providence, Rhode Island, United States
University Cardiology Foundation
Providence, Rhode Island, United States
Ralph H. Johnson VAMC
Charleston, South Carolina, United States
Stern Cardiovascular Center
Memphis, Tennessee, United States
Health Sciences Center
Winnipeg, Manitoba, Canada
Health Sciences Center Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada
London Health Sciences Center
London, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
The Toronto Hospital
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Udelson JE, McGrew FA, Flores E, Ibrahim H, Katz S, Koshkarian G, O'Brien T, Kronenberg MW, Zimmer C, Orlandi C, Konstam MA. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. J Am Coll Cardiol. 2007 Jun 5;49(22):2151-9. doi: 10.1016/j.jacc.2007.01.091. Epub 2007 May 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
156-01-232
Identifier Type: -
Identifier Source: org_study_id